Questions about this study?
The HopeStage team will email you.
TerminatedNCT01592201
A Comparative Study of Patient Satisfaction Between Continued Administration of Previous Antipsychotics Versus Switched Administration to Paliperidone ER in Non-satisfied Patients With Previous Antipsychotic Drug
Medication studyAges 20–65South KoreaSchizophrenia
Understand this study
Who could participate?
Listed age limits: 20 years to 65 years.
- Listed locations
- Busan and 8 more locationsSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateJuly 2012
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 13
- Sponsor
- Janssen Korea, Ltd., Korea
- Sponsor type
- Other organization
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- South Korea
- Age range
- From 20 Years to 65 Years
- Official registry ID
- NCT01592201
- Official title
Show the full official title
An Open-label, Prospective, Randomized and Comparative Study of Patient Satisfaction Between Continued Administration of Previous Antipsychotics Versus Switched Administration to Paliperidone ER in Non-satisfied Patients With Previous Antipsychotic Drug
Recruitment & locations
TerminatedBusan · Cheonan · Chuncheon
6 more locations
- Chungju
- Daegu
- Daejeon
- Goyang-si
- Gyeonggi-do
- Seoul
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is Janssen Korea, Ltd., Korea.
Does this study involve medication?
Yes. The study involves medication, including Paliperdidone ER and Aripiprazole, olanzapine and risperidone (Antipsychotics).
Who can participate?
Listed age limits: 20 years to 65 years.
Is this study still recruiting?
The registry lists this study as terminated.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me